Pfizer's been treading water lately. Nothing dramatic, just calm. But the calm doesn't feel right. What's actually worrying me is patents expiring. That's a real problem down the road. Q1 earnings drop on May 5, and that could either steady the ship or put it back in a holding pattern again. Dividend is still there, which is nice, but I'm just waiting to see the numbers before I do anything.
There are no replies in this thread yet. Be the first to post a reply below: